Paravasthu Mukund's Form 4/A amendment
AmendedNovoCure Ltd (NVCR) · filed Mar 3, 2025
- Accession no.
- 0001562180-25-001912
- Filed
- Mar 3, 2025
- Trade date
- Feb 27-28, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
- Original filed
- Mar 3, 2025
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market sales total $39.7K. It was filed 4 days after the trade.
This amendment replaces 0001562180-25-001831 (filed Mar 3, 2025).
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Paravasthu MukundCIK 0002039078 | Officer (Chief Operating Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 27, 2025 | Ordinary Shares | SSaleDisposed | −1,379 | $19.92 | −$27,469.68 | 30,058 | Direct | |
| Feb 27, 2025 | Ordinary Shares | SSaleDisposed | −267 | $20.55 | −$5,486.85 | 29,791 | Direct | |
| Feb 28, 2025 | Ordinary Shares | SSaleDisposed | −368 | $18.28 | −$6,727.04 | 29,423 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.